跳至主要内容
临床试验/NL-OMON32487
NL-OMON32487尚未招募不适用

Analysis of prostrate-specific immunity in stage III and IV prostate cancer patients - Analysis of prostate-specific immunity

KI-AV0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histologically or cytologically proven stage III or IV prostate carcinoma
  • Age above 18 years
  • PSA increase and/or CT/MRI confirmed progressive disease under antiandrogen treatment (including LH-RH analogues)
  • Performance score: WHO 0,1 or 2 at the time of study entry
  • Written informed consent

排除标准

  • Concurrent treatment with immunosuppressive drugs incl. corticosteroids
  • Undergoing any treatment other than antiandrogen therapy
  • Severe anemia (Hb < 6.0 mmol/L)

研究者

发起方
KI-AV

相似试验